This is not a single article. It's every outletcovering this one event, gathered in one place — read AIPROPX's summary, see where the sources line up, then open any report at its origin.
By AIPROPX Editorial Desk · Published · Updated
Everything reported about this story, gathered from 2 sources. Read the summary below, then tap any source to open that report.

Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates
Summary indexed by AIPROPX from Quartz’s reporting — the full article is one click away. Open at source →
2 outlets are covering this. Resolve the ledger to read what they collectively report — the common thread, in plain terms.
Every report on this story — read the summary of each, then open any at its source. AIPROPX summarizes and links; it never reproduces the original.

Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates
Read this report
CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share
Read this reportEli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
Read this reportAn original, deterministic readout — composed only from the computed coverage facts on this page. No interpretation, no rating; figures only.
AIPROPX has consolidated 3 reports from 2 outlets into a single canonical entry on “Eli Lilly beat earnings and raised its forecast as weight loss drug sales surged.” The covered outlets are based across 2 regions — Other and US.
The earliest report in this entry came from CNBC (Aug 5, 2026, 10:57 UTC); the most recent came from Quartz (Aug 5, 2026, 11:40 UTC).
Comparing the wording across sources, 3 named entities are referenced by multiple outlets and the phrase recurring most across the coverage is “eli lilly”.
3 statements are carried by only one outlet within this set and are not echoed by the others.
Every figure above is a direct count of real published articles. AIPROPX indexes and compares the original reporting — it never rewrites, rates, or editorializes — and each publisher’s full article is always one click away.
Generated by AIPROPX from the source counts above. AIPROPX indexes and resolves coverage; the original publishers are credited and linked at origin in every report.
Coverage from 2 independent outlets across 2 regions — each view opens on its own page.
AIPROPX — “Eli Lilly beat earnings and raised its forecast as weight loss drug sales surged” · https://www.aipropx.com/story/015462313be78fb1433e5c088105387a
Other events being covered across multiple sources right now.
Disney stock pops as parks and streaming powered a big earnings beat
8 outletsStock Market Today: Dow Rises After Surprise Jobs Data; AMD, SpaceX Plunge On Earnings (Live Coverage)
6 outletsDow and S&P 500 Hit Records on AI Earnings: When Will the Bubble Burst?
19 outletsBioventus: Q2 Earnings Snapshot
8 outletsProvidence man pleads guilty to drug trafficking charges
7 outletsRecord EV sales drive new car market to seven-year high